Terms ending in 2031
Every in-force patent on Baxalta Incorporated's record whose computed term ends in 2031, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 8,580,554 | Method of Producing a Polypeptide or Virus of Interest in a Continuous Cell Culture In force · High confidence | Takeda Pharmaceutical Company Limited | In force | High confidence | |
| US 9,650,612 | Method of Producing a Polypeptide or Virus of Interest in a Continuous Cell Culture In force · High confidence | Takeda Pharmaceutical Company Limited | In force | High confidence | |
| US 8,415,114 | Methods of Measuring ADAMTS13-Mediated in Vivo Cleavage of Von Willebrand Factor and Uses Thereof In force · High confidence | Takeda Pharmaceutical Company Limited | In force | High confidence | |
| US 8,304,524 | Manufacture of Factor H (FH) and Fh-Derivatives from Plasma In force · High confidence | Takeda Pharmaceutical Company Limited | In force | High confidence | |
| US 8,450,275 | Tfpi Inhibitors and Methods of Use In force · High confidence | Takeda Pharmaceutical Company Limited | In force | High confidence | |
| US 9,018,167 | Tfpi Inhibitors and Methods of Use In force · Low confidence | Takeda Pharmaceutical Company Limited | In force | Low confidence | |
| US 9,556,230 | Tfpi Inhibitors and Methods of Use In force · Medium confidence | Takeda Pharmaceutical Company Limited | In force | Medium confidence | |
| US 10,201,586 | Tfpi Inhibitors and Methods of Use In force · Low confidence | Takeda Pharmaceutical Company Limited | In force | Low confidence | |
| US 8,796,430 | Method to Produce an Immunoglobulin Preparation with Improved Yield In force · Low confidence | Takeda Pharmaceutical Company Limited | In force | Low confidence | |
| US 8,993,734 | Method to Produce an Immunoglobulin Preparation with Improved Yield In force · Medium confidence | Takeda Pharmaceutical Company Limited | In force | Medium confidence | |
| 27 more term ends in 2031 · Pro | |||||
10 of 37 patents shown. Soonest term end first, then patent number.
Pro members see all 37.
4 of these are in force and held by Baxalta Incorporated.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.